Implementation of the World Health Organization recommendation on the use of rotavirus vaccine without age restriction by African countries. Issue 23 (27th May 2021)

• Record Type: Journal Article
• Authors: Mandomando, Inácio; Mumba, Mutale; Nsiari-muzeyi Biey, Joseph; Kipese Paluku, Gilson; Weldegebriel, Goitom; Mwenda, Jason M.
• Is Part Of: Vaccine. Volume 39:Issue 23(2021)
• Page Start: 3111
• Page End: 3119
• Publication Date: 2021-05-27
• Subjects: Rotavirus -- Vaccine -- Age restriction removal; Vaccines -- Periodicals; 615.372
• DOI: 10.1016/j.vaccine.2021.03.021
• Languages: English
• ISSNs: 0264-410X

Abstract

Abstract: The World Health Organization (WHO) recommended the worldwide use of rotavirus vaccines initially in 2007 and 2009 applying a strict age restriction criterion due to the potential for age-related association with increased risk of intussusception in infants. The restriction was relaxed in the 2013 after detailed review of robust safety data generated in post-marketing surveillance studies. We assessed the status of the implementation of the 2013 recommendation to remove age restriction in the WHO African region (AFR). Of the approximately 75% (35/47) of countries that had introduced the vaccine by 2018, only 43% (15/35) removed age restriction, exclusively from South and East sub-region (78%, 14/18). Avoiding confusion at the health facilities and financial constraints particularly resources required for re-training the health workers, use of vaccine off-label were cited as the main reasons for not implementing the 2013 WHO recommendation on age restriction removal. The 2013 WHO recommendation has not been fully implemented by African countries, suggesting the need for technical advisory bodies to further guide the countries, continue monitoring the implementation status and impact on the rotavirus vaccine coverage and intussusception in the Africa region.